We are live on
!
Find out more
CCA
Conestoga Capital Advisors Portfolio holdings
AUM
$4.6B
1-Year Est. Return
16.08%
This Fund
S&P 500
This Quarter
Est. Return
+27.44%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$6.27B
AUM Growth
+$1.32B
(+27%)
Cap. Flow
+$81.3M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
29.27%
Holding
150
New
7
Increased
71
Reduced
48
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex
VERX
|
+$70M |
| 2 |
MODN
MODEL N, INC.
MODN
|
+$45.2M |
| 3 |
Casella Waste Systems
CWST
|
+$18.2M |
| 4 |
Simulations Plus
SLP
|
+$14.1M |
| 5 |
AVLR
Avalara, Inc.
AVLR
|
+$6.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$42.1M |
| 2 |
Protolabs
PRLB
|
+$36.3M |
| 3 |
Repligen
RGEN
|
+$26.1M |
| 4 |
WD-40
WDFC
|
+$11.2M |
| 5 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$8.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.67% |
| 2 | Industrials | 28.38% |
| 3 | Healthcare | 17.2% |
| 4 | Consumer Discretionary | 8.25% |
| 5 | Materials | 4.76% |
Similar funds
SCM
AG
LNWTC
ANTB
SV
DWM
SCM
LPPI
Conestoga Capital Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Conestoga Capital Advisors held 150 positions worth $6.27B, up 27% from $4.96B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Conestoga Capital Advisors's Q4 2020 filing shows 7 new, 71 increased, 48 reduced and 5 closed positions. Its largest new stake was Vertex: 2,572,160 shares worth $89.6M. The largest sale was Bio-Techne, an estimated $42.1M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.
- Conestoga Capital Advisors's largest Q4 2020 buy was Vertex: 2,572,160 shares worth $89.6M.
- Conestoga Capital Advisors added most to MODEL N, INC. in Q4 2020, an estimated $45.2M increase.
- Conestoga Capital Advisors's biggest Q4 2020 reduction was Bio-Techne, cutting an estimated $42.1M.
- Conestoga Capital Advisors fully exited Protolabs in Q4 2020, selling an estimated $36.3M.
- Conestoga Capital Advisors's ten largest holdings make up 29% of its $6.27B portfolio in Q4 2020.
- Conestoga Capital Advisors opened 7 new positions and closed 5 in Q4 2020.
- Conestoga Capital Advisors's portfolio value rose 27% quarter-over-quarter to $6.27B.
Based on Conestoga Capital Advisors's 13F filing for Q4 2020, filed 26 Jan 2021.